Your browser doesn't support javascript.
loading
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Demetri, G D; Antonescu, C R; Bjerkehagen, B; Bovée, J V M G; Boye, K; Chacón, M; Dei Tos, A P; Desai, J; Fletcher, J A; Gelderblom, H; George, S; Gronchi, A; Haas, R L; Hindi, N; Hohenberger, P; Joensuu, H; Jones, R L; Judson, I; Kang, Y-K; Kawai, A; Lazar, A J; Le Cesne, A; Maestro, R; Maki, R G; Martín, J; Patel, S; Penault-Llorca, F; Premanand Raut, C; Rutkowski, P; Safwat, A; Sbaraglia, M; Schaefer, I-M; Shen, L; Serrano, C; Schöffski, P; Stacchiotti, S; Sundby Hall, K; Tap, W D; Thomas, D M; Trent, J; Valverde, C; van der Graaf, W T A; von Mehren, M; Wagner, A; Wardelmann, E; Naito, Y; Zalcberg, J; Blay, J-Y.
Affiliation
  • Demetri GD; Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, USA.
  • Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Bjerkehagen B; Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Boye K; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Chacón M; Oncology Service Chair, Instituto Alexander Fleming, Buenos Aires, Argentina.
  • Dei Tos AP; Department of Pathology, University of Padua, Padova, Italy.
  • Desai J; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Fletcher JA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • George S; Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Haas RL; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hindi N; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain; Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain.
  • Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Center, Mannheim, Germany.
  • Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Division of Clinical Studies, Institute of Cancer Research, London, UK.
  • Judson I; Division of Clinical Studies, Institute of Cancer Research, London, UK.
  • Kang YK; Department of Oncology, University of Ulsan College of Medicine, Seoul, Korea.
  • Kawai A; Department of Musculoskeletal Oncology, National Cancer Center, Tokyo, Japan.
  • Lazar AJ; Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Le Cesne A; Medical Oncology, Insitut Gustave Roussy, Villejuif, Ile-de-France, France.
  • Maestro R; Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy.
  • Maki RG; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
  • Martín J; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain; Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain.
  • Patel S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Penault-Llorca F; Centre Jean Perrin, Clermont-Ferrand, France.
  • Premanand Raut C; Division of Surgical Oncology, Brigham and Women's Hospital, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Safwat A; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Sbaraglia M; Department of Pathology, University of Padua, Padova, Italy.
  • Schaefer IM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Shen L; Department of GI Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
  • Serrano C; Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain.
  • Schöffski P; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Stacchiotti S; Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Sundby Hall K; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Tap WD; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.
  • Thomas DM; The Kinghorn Cancer Centre and Cancer Theme, Garvan Institute of Medical Research, Darlinghurst, Australia.
  • Trent J; Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, Miami, USA.
  • Valverde C; Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain.
  • van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • von Mehren M; Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, USA.
  • Wagner A; Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA.
  • Wardelmann E; Gerhard Domagk Institute of Pathology, University of Münster, Münster, Germany.
  • Naito Y; National Cancer Center Hospital East, Kashiwa, Japan.
  • Zalcberg J; Department of Epidemiology and Preventative Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medical Oncology, Alfred Health, Melbourne, Australia.
  • Blay JY; Centre Léon Bérard, Unicancer, LYRICAN and Université Claude Bernard Lyon 1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
Ann Oncol ; 31(11): 1506-1517, 2020 11.
Article in En | MEDLINE | ID: mdl-32891793
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Tropomyosin Type of study: Diagnostic_studies / Guideline Limits: Adult / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Tropomyosin Type of study: Diagnostic_studies / Guideline Limits: Adult / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: United States